Cargando…
Development and application of hyaluronic acid in tumor targeting drug delivery
Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its receptor, CD44, is overexpressed in many kinds of cancers and is associated with tumor progress, infiltration and metastas...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900560/ https://www.ncbi.nlm.nih.gov/pubmed/31867159 http://dx.doi.org/10.1016/j.apsb.2019.06.004 |
_version_ | 1783477372768485376 |
---|---|
author | Luo, Zhijian Dai, Yan Gao, Huile |
author_facet | Luo, Zhijian Dai, Yan Gao, Huile |
author_sort | Luo, Zhijian |
collection | PubMed |
description | Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its receptor, CD44, is overexpressed in many kinds of cancers and is associated with tumor progress, infiltration and metastasis. Therefore, many researchers have developed various HA-based drug delivery systems for CD44-mediated tumor targeting. In this review, we systemically overview the basic theory of HA, its receptor and hyaluronidase, then we categorize the studies in HA-based drug delivery systems according to the functions of HA, including tumor-targeting materials, enzyme-sensitive biodegradable modality, pH-sensitive component, reduction-sensitive component, and the gel backbone. Finally, the perspective is discussed. |
format | Online Article Text |
id | pubmed-6900560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-69005602019-12-20 Development and application of hyaluronic acid in tumor targeting drug delivery Luo, Zhijian Dai, Yan Gao, Huile Acta Pharm Sin B Review Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its receptor, CD44, is overexpressed in many kinds of cancers and is associated with tumor progress, infiltration and metastasis. Therefore, many researchers have developed various HA-based drug delivery systems for CD44-mediated tumor targeting. In this review, we systemically overview the basic theory of HA, its receptor and hyaluronidase, then we categorize the studies in HA-based drug delivery systems according to the functions of HA, including tumor-targeting materials, enzyme-sensitive biodegradable modality, pH-sensitive component, reduction-sensitive component, and the gel backbone. Finally, the perspective is discussed. Elsevier 2019-11 2019-06-20 /pmc/articles/PMC6900560/ /pubmed/31867159 http://dx.doi.org/10.1016/j.apsb.2019.06.004 Text en © 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Luo, Zhijian Dai, Yan Gao, Huile Development and application of hyaluronic acid in tumor targeting drug delivery |
title | Development and application of hyaluronic acid in tumor targeting drug delivery |
title_full | Development and application of hyaluronic acid in tumor targeting drug delivery |
title_fullStr | Development and application of hyaluronic acid in tumor targeting drug delivery |
title_full_unstemmed | Development and application of hyaluronic acid in tumor targeting drug delivery |
title_short | Development and application of hyaluronic acid in tumor targeting drug delivery |
title_sort | development and application of hyaluronic acid in tumor targeting drug delivery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900560/ https://www.ncbi.nlm.nih.gov/pubmed/31867159 http://dx.doi.org/10.1016/j.apsb.2019.06.004 |
work_keys_str_mv | AT luozhijian developmentandapplicationofhyaluronicacidintumortargetingdrugdelivery AT daiyan developmentandapplicationofhyaluronicacidintumortargetingdrugdelivery AT gaohuile developmentandapplicationofhyaluronicacidintumortargetingdrugdelivery |